Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2016

01-11-2016 | Epidemiology

Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988–2013

Authors: Allison W. Kurian, Alison J. Canchola, Scarlett L. Gomez, Christina A. Clarke

Published in: Breast Cancer Research and Treatment | Issue 2/2016

Login to get access

ABSTRACT

Purpose

Nipple-sparing mastectomy, which may improve cosmesis, body image, and sexual function in comparison to non-nipple-sparing mastectomy, is increasingly used to treat early-stage breast cancer; however, long-term survival data are lacking. We evaluated survival after nipple-sparing mastectomy versus non-nipple-sparing mastectomy in a population-based cancer registry.

Methods

We conducted an observational study using the California Cancer Registry, considering all stage 0–III breast cancers diagnosed in California from 1988 to 2013. We compared breast cancer-specific and overall survival time after nipple-sparing versus non-nipple-sparing mastectomy, using multivariable analysis.

Results

Among 157,592 stage 0–III female breast cancer patients treated with unilateral mastectomy from 1988–2013, 993 (0.6 %) were reported as having nipple-sparing and 156,599 (99.4 %) non-nipple-sparing mastectomies; median follow-up was 7.9 years. The proportion of mastectomies that were nipple-sparing increased over time (1988, 0.2 %; 2013, 5.1 %) and with neighborhood socioeconomic status, and decreased with age and stage. On multivariable analysis, nipple-sparing mastectomy was associated with a lower risk of breast cancer-specific mortality compared to non-nipple-sparing mastectomy [hazard ratio (HR) 0.71, 95 % confidence interval (CI) 0.51–0.98]. However, when restricting to diagnoses 1996 or later and adjusting for a larger set of covariates, risk was attenuated (HR 0.86, 95 % CI 0.52–1.42).

Conclusions

Among California breast cancer patients diagnosed from 1988–2013, nipple-sparing mastectomy was not associated with worse survival than non-nipple-sparing mastectomy. These results may inform the decisions of patients and doctors deliberating between these surgical approaches for breast cancer treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241CrossRefPubMed Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241CrossRefPubMed
2.
go back to reference Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312:902–914CrossRefPubMed Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312:902–914CrossRefPubMed
3.
go back to reference Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088CrossRefPubMedPubMedCentral Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082–4088CrossRefPubMedPubMedCentral
4.
go back to reference Jagsi R, Kurian AW, Griffith KA, Hamilton AS, Ward KC, Hawley ST, Morrow M, Katz SJ (2015) Genetic testing decisions of breast cancer patients: results from the iCanCare study. Abstract presented at the American Society of Clinical Oncology Annual Meeting. Chicago, IL, June 2015 Jagsi R, Kurian AW, Griffith KA, Hamilton AS, Ward KC, Hawley ST, Morrow M, Katz SJ (2015) Genetic testing decisions of breast cancer patients: results from the iCanCare study. Abstract presented at the American Society of Clinical Oncology Annual Meeting. Chicago, IL, June 2015
5.
go back to reference Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975CrossRefPubMedPubMedCentral Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975CrossRefPubMedPubMedCentral
6.
go back to reference de Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS (2011) Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol 18:3117–3122CrossRef de Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS (2011) Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol 18:3117–3122CrossRef
7.
go back to reference Metcalfe KA, Cil TD, Semple JL et al (2015) Long-term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple-areolar complex make a difference? Ann Surg Oncol 22:3324–3330CrossRefPubMed Metcalfe KA, Cil TD, Semple JL et al (2015) Long-term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple-areolar complex make a difference? Ann Surg Oncol 22:3324–3330CrossRefPubMed
8.
go back to reference Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12:703–711CrossRefPubMed Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12:703–711CrossRefPubMed
9.
go back to reference Piper M, Peled AW, Foster RD, Moore DH, Esserman LJ (2013) Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg 70:435–437CrossRefPubMed Piper M, Peled AW, Foster RD, Moore DH, Esserman LJ (2013) Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg 70:435–437CrossRefPubMed
10.
go back to reference Adam H, Bygdeson M, de Boniface J (2014) The oncological safety of nipple-sparing mastectomy—a Swedish matched cohort study. Eur J Surg Oncol 40:1209–1215CrossRefPubMed Adam H, Bygdeson M, de Boniface J (2014) The oncological safety of nipple-sparing mastectomy—a Swedish matched cohort study. Eur J Surg Oncol 40:1209–1215CrossRefPubMed
11.
go back to reference Agarwal S, Agarwal S, Neumayer L, Agarwal JP (2014) Therapeutic nipple-sparing mastectomy: trends based on a national cancer database. Am J Surg 208:93–98CrossRefPubMed Agarwal S, Agarwal S, Neumayer L, Agarwal JP (2014) Therapeutic nipple-sparing mastectomy: trends based on a national cancer database. Am J Surg 208:93–98CrossRefPubMed
12.
go back to reference Seki T, Jinno H, Okabayashi K et al (2015) Comparison of oncological safety between nipple sparing mastectomy and total mastectomy using propensity score matching. Ann R Coll Surg Engl 97:291–297CrossRefPubMedPubMedCentral Seki T, Jinno H, Okabayashi K et al (2015) Comparison of oncological safety between nipple sparing mastectomy and total mastectomy using propensity score matching. Ann R Coll Surg Engl 97:291–297CrossRefPubMedPubMedCentral
13.
go back to reference Yao K, Liederbach E, Tang R et al (2015) Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol 22:370–376CrossRefPubMed Yao K, Liederbach E, Tang R et al (2015) Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol 22:370–376CrossRefPubMed
14.
go back to reference Orzalesi L, Casella D, Santi C et al (2016) Nipple sparing mastectomy: surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a 6 year period. Breast 25:75–81CrossRefPubMed Orzalesi L, Casella D, Santi C et al (2016) Nipple sparing mastectomy: surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a 6 year period. Breast 25:75–81CrossRefPubMed
Metadata
Title
Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988–2013
Authors
Allison W. Kurian
Alison J. Canchola
Scarlett L. Gomez
Christina A. Clarke
Publication date
01-11-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3992-8

Other articles of this Issue 2/2016

Breast Cancer Research and Treatment 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine